Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yishen Jiangzhuo herbal decoction is a traditional Chinese medicine (TCM) formulation developed for the treatment of chronic kidney disease (CKD) and its complications, such as renal anemia. It is composed of a mixture of herbs including Pseudostellaria, Atractylodes macrocephala, Astragalus, Poria cocos, rhubarb, tangerine peel, angelica, mulberry, salvia, achyranthes bidentata, plantain seed, Serissa japonica, and motherwort. The decoction is designed to improve renal function, reduce serum creatinine (Scr), blood urea nitrogen (BUN), and C-reactive protein (CRP) levels, and increase red blood cell (RBC), hemoglobin (Hb), and hematocrit (HCT) levels. It works by stimulating bone marrow hematopoiesis, promoting erythropoiesis, and exerting anti-inflammatory and antioxidative effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yishen Jiangzhuo herbal decoction.